Full-Time

Project Manager

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Senior, Expert

Hyderabad, Telangana, India

Category
Project Management
Legal & Compliance
Business & Strategy
Required Skills
Agile
JIRA
Requirements
  • Doctorate Degree OR
  • Master’s degree with 4 - 6 years of experience in Computer Science, IT or related field OR
  • Bachelor’s degree with 6 - 8 years of experience in Computer Science, IT or related field OR
  • Diploma with 10 - 12 years of experience in Computer Science, IT or related field
  • Proven track record of delivering high impact projects that meet and exceed the project objectives and success measures
  • Ability to proactively chart the course for project delivery and effectively work through project risks and challenges to successfully deliver business outcomes
  • Extensive knowledge of program and project management methodologies
  • Experience and strong knowledge of portfolio management methodologies and frameworks
  • Cost & Budget management with detailed financial tracking experience of projects and/or programs with ongoing status reporting to stakeholders
  • Strong knowledge of change management principles and methodologies
  • Experience successfully delivering technology enabling projects that produce tangible outcomes and business value
  • Experience with Agile delivery – Product team participation and experience
  • Experience with project analysis tools such as Plangrid, Jira, Bluebeam, eBuilder, MS Project, etc.
Responsibilities
  • Define project / program scope, goals, and deliverables that support business goals and objectives in collaboration with senior management and stakeholders
  • Lead the project team in executing the project plan, monitoring progress, and making adjustments as needed
  • Deliver successfully against project schedule, scope, and financial commitments
  • Maintain budgetary responsibility of the project(s)
  • Implementation of cost saving measures based on planning and efficiency
  • Identify potential risks and develop mitigation strategies
  • Ensure that project deliverables meet quality standards, business requirements, and intended outcomes
  • Maintain comprehensive project documentation, including plans, reports, and post-project evaluations
  • Coordinate resources across projects, managing dependencies and resolving conflicts
  • Track ongoing program performance throughout using appropriate tools and techniques, ensuring that the program delivers the expected benefits
Desired Qualifications
  • Proficiency with program management software and tools
  • Proven ability to execute and deliver on a complex portfolio of projects and programs
  • Experience with delivering successful organizational change initiatives and transformations
  • Experience delivering GxP projects in the life sciences space and successfully taking through the required qualification processes (e.g., IQ, OQ, PQ, etc.)
  • Project Management Professional (PMP) or equivalent certification (preferred)
  • Certified Change Management Professional (CCMP) or equivalent (preferred)

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are medicines made from living organisms. These therapies target conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen stands out from competitors by reinvesting a large portion of its earnings into research and development, ensuring a strong pipeline of new treatments. The goal of Amgen is to improve patient care and outcomes through the discovery of effective therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.